In addition to these roles, P2X7 receptors also modulate the tumor microenvironment wherein blockade of the receptors through systemic administration of A740003 showed an increase in CD4+ cells but with diminished expression of ectonucleotidases, CD39 and CD73 (De Marchi et al., 2019). The gene discussed is P2RX7; the disease is neoplasm.